Venture Life makes healthcare and cosmetic products for the over-40s
What is it? Venture Life makes healthcare and cosmetic products for the over-40s.
These include food supplements for lowering cholesterol and maintaining brain function, anti-ageing creams, eye treatments and devices to ease conditions such as haemorrhoids.
What’s the latest? On Thursday, shares surged 1 per cent after two key updates were announced.
Firstly, it has partnered with a European pharmaceutical sales firm to market and sell its popular mouthwash UltraDEX in Italy from early next year.
It also announced the first group of long-term distribution agreements for its fungal nail treatment Myco-Clear.
The updates come hot on the heels of Venture’s trading update for the first half of the year that revealed a 28 per cent jump in year-on-year revenues to £7.8million.
Who backs it? Manufacturing director Gianluca Braguti is the biggest shareholder with 19.2 per cent. Chief executive and co-founder Jerry Randall owns 10.7 per cent.
Why should you invest? A number of positive developments across its product range in recent months is a good sign. It has also secured entry into the massive Chinese market, as well as growing in Europe.
Products are still being rolled out at a relatively slow pace, but as this picks up it could be worth being part of the ride.
And why you shouldn’t Venture Life is a very small player, and some investors may want more scale and evidence of success before buying shares.